Carlo Tanzi | Head of IR |
Eric Shaff | President & CEO |
Lisa von Moltke | Chief Medical Officer |
Matthew Henn | Chief Scientific Officer |
David Arkowitz | CFO |
Terri Young | Chief Commercial and Strategy Officer |
David Ege | Chief Technology Officer |
Mark Breidenbach | Oppenheimer |
Peyton Bohnsack | Cowen |
John Newman | Canaccord |
Ted Tenthoff | Piper Sandler |
Chris Howerton | Jeffries |
Chris Shibutani | Goldman Sachs |
Good day, and thank you for standing by. Welcome to the Q2 2022 Seres Therapeutics, Inc. Earnings Conference Call. At lines have been placed on mute to prevent any background noise. [Operator Instructions] During today’s call there will be question-and-answer session.